AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30504569 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (2400 mg/d, tid) + pulsed radiofrequency lesioning of the dorsal root ganglion
Number of subjects: 116
Study 30504569 — intervention group
Group type: COMPARATOR
Intervention: Oral gabapentin (2400 mg/d, tid)
Number of subjects: 116
Study 27240921 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral L-tryptophan (30, 60 or 120 mg/kg body weight)
Number of subjects: 60
Study 27240921 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 25630245 — intervention group
Group type: EXPERIMENTAL
Intervention: Antagonist passive static stretching (AS) for 40 seconds applied to pectoralis major prior to each set of seated row (SR)
Number of subjects: 10
Study 25630245 — intervention group
Group type: EXPERIMENTAL
Intervention: Antagonist passive static stretching (AS)
Number of subjects: 10
Study 25630245 — intervention group
Group type: COMPARATOR
Intervention: Passive recovery (PR)
Number of subjects: 10
Study 23895804 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stent (EES)
Number of subjects: 2600
Study 23895804 — intervention group
Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stent with biolinx polymer (ZES-R)
Number of subjects: 2600
Study 23895804 — intervention group
Group type: EXPERIMENTAL
Intervention: Biolimus-eluting stent (BES)
Number of subjects: 2600
Study 20619837 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 mg)
Number of subjects: 0
Study 20619837 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate (160 mg)
Number of subjects: 0
Study 20619837 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of atorvastatin and fenofibrate
Number of subjects: 0
Study 18199184 — intervention group
Group type: EXPERIMENTAL
Intervention: Solution-focused group therapy (SFGT)
Number of subjects: 0
Study 18199184 — intervention group
Group type: COMPARATOR
Intervention: Traditional problem-focused treatment
Number of subjects: 0
Study 16523206 — intervention group
Group type: EXPERIMENTAL
Intervention: EFA‐supplemented test‐treatment formula
Number of subjects: 53
Study 16523206 — intervention group
Group type: COMPARATOR
Intervention: Fat-free control formula
Number of subjects: 53
Study 12895320 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamivudine 100 mg daily
Number of subjects: 429
Study 10983204 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-tiered hospital-approved disciplinary action
Number of subjects: 1638
Study 8646820 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of midazolam (2 mg)
Number of subjects: 20
Study 8646820 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of midazolam (1 mg)
Number of subjects: 20
Study 8646820 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro studies of CYP3A-mediated formation of 1'‐hydroxymidazolam
Number of subjects: 20
Study 1345890 — intervention group
Group type: EXPERIMENTAL
Intervention: BRL 26830A
Number of subjects: 40
Study 1345890 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 31871697 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational brochures and films about diabetes prevention (N=154)
Number of subjects: 311
Study 31871697 — intervention group
Group type: COMPARATOR
Intervention: No intervention (N=157)
Number of subjects: 311
Study 29266804 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivabradine
Number of subjects: 38
Study 29266804 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 26094771 — intervention group
Group type: EXPERIMENTAL
Intervention: Supragingival scaling
Number of subjects: 52
Study 26094771 — intervention group
Group type: EXPERIMENTAL
Intervention: RA group
Number of subjects: 52
Study 24902406 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTIVA BioACTIVE‐CEMENT/BASE/LINER
Number of subjects: 40
Study 24902406 — intervention group
Group type: EXPERIMENTAL
Intervention: FujiCem2
Number of subjects: 40
Study 24902406 — intervention group
Group type: EXPERIMENTAL
Intervention: Embrace WetBond
Number of subjects: 40
Study 24902406 — intervention group
Group type: COMPARATOR
Intervention: zinc phosphate cement
Number of subjects: 40
Study 22434523 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (daily calcium 1 g and vitamin D(3) 800 IU, plus additional oral 16,000 IU every 2 weeks if baseline 25(OH)D <30 ng/ml)
Number of subjects: 232
Study 21245499 — intervention group
Group type: EXPERIMENTAL
Intervention: CT extension
Number of subjects: 40
Study 21245499 — intervention group
Group type: EXPERIMENTAL
Intervention: CT flexion
Number of subjects: 40
Study 21245499 — intervention group
Group type: EXPERIMENTAL
Intervention: CC extension
Number of subjects: 40
Study 21245499 — intervention group
Group type: EXPERIMENTAL
Intervention: CC flexion
Number of subjects: 40
Study 21245499 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensor to flexor strength ratio at CT axis
Number of subjects: 40
Study 21245499 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensor to flexor strength ratio at CC axis
Number of subjects: 40
Study 21245499 — intervention group
Group type: EXPERIMENTAL
Intervention: Test-retest repeatability (all tests)
Number of subjects: 40
Study 17852958 — intervention group
Group type: EXPERIMENTAL
Intervention: Health-promotion programme
Number of subjects: 229
Study 17852958 — intervention group
Group type: COMPARATOR
Intervention: Individual intervention
Number of subjects: 229
Study 19305697 — intervention group
Group type: EXPERIMENTAL
Intervention: Income-based pharmacare policy change in 2003
Number of subjects: 795071
Study 19305697 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-payment introduced in 2002
Number of subjects: 795071
Study 14612828 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 180
Study 14612828 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac
Number of subjects: 180
Study 11115795 — intervention group
Group type: COMPARATOR
Intervention: N-acetylcysteine
Number of subjects: 0
Study 8668568 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide/oxygen (N2O)
Number of subjects: 20
Study 8668568 — intervention group
Group type: COMPARATOR
Intervention: Oxygen (O2)
Number of subjects: 20
Study 1460158 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated systemic therapy (IST)
Number of subjects: 0
Study 1460158 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotionally focused therapy (EFT)
Number of subjects: 0
Study 1460158 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 6425033 — intervention group
Group type: EXPERIMENTAL
Intervention: One nitroglycerin plaster (5 mg liberation within 24 hours)
Number of subjects: 24
Study 6425033 — intervention group
Group type: EXPERIMENTAL
Intervention: Two nitroglycerin plasters (5 mg liberation within 24 hours)
Number of subjects: 24
Study 6425033 — intervention group
Group type: EXPERIMENTAL
Intervention: Four nitroglycerin plasters (5 mg liberation within 24 hours)
Number of subjects: 24
Study 6425033 — intervention group
Group type: COMPARATOR
Intervention: 20 mg 5‐isosorbide mononitrate (ISMN)
Number of subjects: 24
Study 31586443 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobilization tool
Number of subjects: 60
Study 31586443 — intervention group
Group type: COMPARATOR
Intervention: Comparator tool
Number of subjects: 60
Study 29887537 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dietary cholesterol intake (1 SD increase) in nonemployed men
Number of subjects: 1039
Study 29887537 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dietary cholesterol intake (1 SD increase) in less educated men
Number of subjects: 1039
Study 29887537 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dietary cholesterol intake (1 SD increase) in employed men
Number of subjects: 1039
Study 29887537 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dietary cholesterol intake (1 SD increase) in more educated men
Number of subjects: 1039
Study 29140826 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted walking training with rhythmic arm swing
Number of subjects: 20
Study 29140826 — intervention group
Group type: COMPARATOR
Intervention: Control group performing training in arm fixation
Number of subjects: 20
Study 27941179 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed oil supplementation for three months
Number of subjects: 0
Study 27941179 — intervention group
Group type: COMPARATOR
Intervention: Safflower oil treatment for three months
Number of subjects: 0
Study 24561815 — intervention group
Group type: EXPERIMENTAL
Intervention: COLD (cold water bath at 10°C for 15 min)
Number of subjects: 9
Study 24561815 — intervention group
Group type: COMPARATOR
Intervention: CON (control leg outside the water bath)
Number of subjects: 9
Study 22585532 — intervention group
Group type: EXPERIMENTAL
Intervention: FT laparoscopic operation
Number of subjects: 163
Study 22585532 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 163
Study 21166343 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine hydrochloride for 3 months
Number of subjects: 85
Study 21166343 — intervention group
Group type: COMPARATOR
Intervention: Control group (stroke patients without depression)
Number of subjects: 85
Study 18308580 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine (250 microg/kg) added to blood cardioplegia
Number of subjects: 40
Study 18308580 — intervention group
Group type: COMPARATOR
Intervention: Control group (only antegrade cardioplegia)
Number of subjects: 40
Study 16041209 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial-impregnated catheters (minocycline and rifampin)
Number of subjects: 346
Study 16041209 — intervention group
Group type: COMPARATOR
Intervention: Tunneled catheters
Number of subjects: 346
Study 12503837 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (5 mg/day titrated to 20 mg/day)
Number of subjects: 12
Study 12503837 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 10424419 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS) over primary motor cortex (MI)
Number of subjects: 7
Study 10424419 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS) over FCz
Number of subjects: 7
Study 7472629 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse managed special care unit
Number of subjects: 0
Study 7472629 — intervention group
Group type: COMPARATOR
Intervention: Traditional intensive care units
Number of subjects: 0
Study 2265045 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 1.5 micrograms kg‐1 5 min before induction of anaesthesia
Number of subjects: 17
Study 2265045 — intervention group
Group type: COMPARATOR
Intervention: Control group (no fentanyl)
Number of subjects: 17
Study 2265045 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 2.5 mg kg‐1
Number of subjects: 17
Study 6777109 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy exercise (70% maximum power)
Number of subjects: 5
Study 6777109 — intervention group
Group type: COMPARATOR
Intervention: Light exercise (36% maximum power)
Number of subjects: 5
Study 31709903 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevention of Post‐Rape Stress (PPRS) video intervention
Number of subjects: 233
Study 31709903 — intervention group
Group type: COMPARATOR
Intervention: Pleasant Imagery and Relaxation Instruction (PIRI) video intervention
Number of subjects: 233
Study 31709903 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 233
Study 31574862 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed AFO
Number of subjects: 50
Study 31574862 — intervention group
Group type: EXPERIMENTAL
Intervention: Articulated AFO
Number of subjects: 50
Study 28209343 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal vaccination
Number of subjects: 347
Study 28209343 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular vaccination
Number of subjects: 347
Study 25458756 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-centred tobacco control programme
Number of subjects: 26
Study 24006861 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ocular hypotensive medication for 12 weeks
Number of subjects: 164
Study 21236411 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep anterior lamellar keratoplasty (DALK)
Number of subjects: 53
Study 21236411 — intervention group
Group type: COMPARATOR
Intervention: Penetrating keratoplasty (PK)
Number of subjects: 53
Study 19764167 — intervention group
Group type: EXPERIMENTAL
Intervention: Transposition at two months post-fitting (V4)
Number of subjects: 8
Study 19764167 — intervention group
Group type: COMPARATOR
Intervention: Transposition at initial fit (V2)
Number of subjects: 8
Study 19764167 — intervention group
Group type: COMPARATOR
Intervention: Transposition at one month post-fit (V3)
Number of subjects: 8
Study 18193499 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral intervention (15 sessions, 90 minutes each) focusing on Stress, Coping, and Adjustment; Safer Behaviors; and Health Behaviors, including ART adherence.
Number of subjects: 204
Study 18193499 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention until trial completion).
Number of subjects: 204
Study 12027908 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ)
Number of subjects: 23
Study 12027908 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (GBP)
Number of subjects: 23
Study 12027908 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated subjects)
Number of subjects: 23
Study 9607529 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous cephazolin 1 g every 6 h and gentamicin 80 mg every 8 h for 7 days
Number of subjects: 127
Study 9607529 — intervention group
Group type: COMPARATOR
Intervention: No antibiotics until the appearance of infective complications
Number of subjects: 127
Study 7530585 — intervention group
Group type: EXPERIMENTAL
Intervention: Nevirapine 200 mg/day in combination with zidovudine 200 mg q8h
Number of subjects: 62
Study 7530585 — intervention group
Group type: EXPERIMENTAL
Intervention: Nevirapine at doses of 12.5, 50, and 200 mg/day
Number of subjects: 62
Study 7530585 — intervention group
Group type: EXPERIMENTAL
Intervention: Nevirapine alone or in combination with zidovudine
Number of subjects: 62
Study 7530585 — intervention group
Group type: EXPERIMENTAL
Intervention: Nevirapine
Number of subjects: 62
Study 2223677 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic oral salbutamol (74 women)
Number of subjects: 144
Study 2223677 — intervention group
Group type: COMPARATOR
Intervention: Placebo (70 women)
Number of subjects: 144
Study 395632 — intervention group
Group type: EXPERIMENTAL
Intervention: Phthalylsulphathiazole
Number of subjects: 0
Study 395632 — intervention group
Group type: COMPARATOR
Intervention: Faeces
Number of subjects: 0
Study 30889600 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning to read the non-extension sign through a 60-minute lecture.
Number of subjects: 35
Study 31221206 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic placement of Phasix™ mesh in an onlay position
Number of subjects: 0
Study 31221206 — intervention group
Group type: COMPARATOR
Intervention: Standardized abdominal closure without mesh
Number of subjects: 0
Study 27839752 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine‐impregnated antiseptic washcloths
Number of subjects: 122
Study 27839752 — intervention group
Group type: COMPARATOR
Intervention: Nonantiseptic bathing
Number of subjects: 122
Study 25844702 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental system for bedside EDPS process guidance
Number of subjects: 24
Study 25844702 — intervention group
Group type: COMPARATOR
Intervention: Control group (no experimental system)
Number of subjects: 24
Study 25844702 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (with experimental system)
Number of subjects: 24
Study 25844702 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study 23829508 — intervention group
Group type: EXPERIMENTAL
Intervention: HM30181 at doses ≥10 mg
Number of subjects: 25
Study 23829508 — intervention group
Group type: COMPARATOR
Intervention: Loperamide (16 mg)
Number of subjects: 25
Study 23829508 — intervention group
Group type: EXPERIMENTAL
Intervention: HM30181 (1, 5, 10, 15 mg)
Number of subjects: 25
Study 23829508 — intervention group
Group type: EXPERIMENTAL
Intervention: HM30181
Number of subjects: 25
Study 22364054 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler method for measuring systolic blood pressure (SBP)
Number of subjects: 20
Study 22364054 — intervention group
Group type: COMPARATOR
Intervention: Stethoscope method for measuring systolic blood pressure (SBP)
Number of subjects: 20
Study 22364054 — intervention group
Group type: COMPARATOR
Intervention: Comparison of Doppler and Stethoscope methods for determining ABI
Number of subjects: 20
Study 22364054 — intervention group
Group type: COMPARATOR
Intervention: Linear regression analysis of Doppler and Stethoscope methods for ABI
Number of subjects: 20
Study 19583934 — intervention group
Group type: EXPERIMENTAL
Intervention: Needling at SJ5
Number of subjects: 16
Study 19583934 — intervention group
Group type: EXPERIMENTAL
Intervention: Needling at SJ5 plus GB34
Number of subjects: 16
Study 16735965 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforced follow-up group (RFG)
Number of subjects: 100
Study 16735965 — intervention group
Group type: COMPARATOR
Intervention: Usual follow-up group (UFG)
Number of subjects: 100
Study 15655271 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous simvastatin 10 mg/day for four months
Number of subjects: 40
Study 15655271 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent simvastatin 20 mg three times a week for four months
Number of subjects: 40
Study 15655271 — intervention group
Group type: COMPARATOR
Intervention: Control group (diet only)
Number of subjects: 40
Study 10754624 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl concentration of 0.72 +/- 0.07 ng/ml
Number of subjects: 25
Study 10754624 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl concentration of 0.94 +/- 0.06 ng/ml
Number of subjects: 25
Study 8607590 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-protein diet
Number of subjects: 1521
Study 8607590 — intervention group
Group type: COMPARATOR
Intervention: Usual-protein diet
Number of subjects: 1521
Study 1845927 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholangiocarcinoma in patients with primary sclerosing cholangitis
Number of subjects: 30
Study 1845927 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy for primary sclerosing cholangitis
Number of subjects: 30
Study 6683540 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 0
Study 6683540 — intervention group
Group type: COMPARATOR
Intervention: Pentazocine
Number of subjects: 0
Study 30022574 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Information Leaflet (PIL)
Number of subjects: 96
Study 30022574 — intervention group
Group type: COMPARATOR
Intervention: Drug Monograph
Number of subjects: 96
Study 28475268 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen A (standard treatment)
Number of subjects: 874
Study 28475268 — intervention group
Group type: COMPARATOR
Intervention: Regimen B (additional doxorubicin and cyclophosphamide/cytarabine)
Number of subjects: 874
Study 28475268 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic HRQoL
Number of subjects: 874
Study 28475268 — intervention group
Group type: EXPERIMENTAL
Intervention: Age and gender effects
Number of subjects: 874
Study 28475268 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of delayed intensifications (DIs)
Number of subjects: 874
Study 27281811 — intervention group
Group type: EXPERIMENTAL
Intervention: PRO+EX (40 g protein with evening physical activity)
Number of subjects: 23
Study 27281811 — intervention group
Group type: COMPARATOR
Intervention: PRO (40 g protein without evening physical activity)
Number of subjects: 23
Study 25783650 — intervention group
Group type: EXPERIMENTAL
Intervention: Salpingectomy
Number of subjects: 160
Study 25783650 — intervention group
Group type: COMPARATOR
Intervention: Aspiration
Number of subjects: 160
Study 25783650 — intervention group
Group type: EXPERIMENTAL
Intervention: Salpingectomy (vs. rapid re-accumulation subgroup)
Number of subjects: 160
Study 25783650 — intervention group
Group type: COMPARATOR
Intervention: Rapid re-accumulation subgroup
Number of subjects: 160
Study 25783650 — intervention group
Group type: EXPERIMENTAL
Intervention: Salpingectomy (vs. no re-accumulation subgroup)
Number of subjects: 160
Study 25783650 — intervention group
Group type: COMPARATOR
Intervention: No re-accumulation subgroup
Number of subjects: 160
Study 22550052 — intervention group
Group type: EXPERIMENTAL
Intervention: Total cholesterol
Number of subjects: 2743
Study 22550052 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic blood pressure
Number of subjects: 2743
Study 22550052 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 2743
Study 22550052 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex and age
Number of subjects: 2743
Study 20122945 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisensory illusion using fake hands smaller or larger than the participant's hand
Number of subjects: 0
Study 18602522 — intervention group
Group type: EXPERIMENTAL
Intervention: Diastolic HF
Number of subjects: 228
Study 15783351 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiscale entropy (MSE) method applied to human heartbeat fluctuations
Number of subjects: 0
Study 15783351 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiscale entropy (MSE) method applied to coding and noncoding DNA sequences
Number of subjects: 0
Study 12401759 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion
Number of subjects: 79
Study 12401759 — intervention group
Group type: COMPARATOR
Intervention: Insulin injection
Number of subjects: 79
Study 10330958 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymoglobulin
Number of subjects: 0
Study 10330958 — intervention group
Group type: COMPARATOR
Intervention: Atgam
Number of subjects: 0
Study 8792953 — intervention group
Group type: EXPERIMENTAL
Intervention: Dornase alfa
Number of subjects: 0
Study 2189429 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral physostigmine
Number of subjects: 23
Study 2189429 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 16793 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam 0.5 mg
Number of subjects: 0